Searched for
TORRENT CIPLA ACQUISITION
Cipla faces revenue and margin pressure ahead of Revlimid patent expiryCipla faces revenue and margin pressure due to the upcoming Revlimid patent expiry, leading to underperformance and analyst downgrades. Mar...- Torrent Pharma closes in on JB Chem likely for $2.4 bn buyout, eyes $1.6 billion financingTorrent Pharma is in advanced talks with KKR to acquire JB Chemicals and Pharmaceuticals, reviving discussions from last year. The deal inv...
- Torrent Pharma keen to break into big leagueTorrent Pharma, currently seventh in India, is aimingto break into the top three drugmakers within five years through strategic acquisition...
- Alkem joins $3 bn race for JB Chem as Torrent pauses talksAlkem Laboratories, India's fifth-largest branded pharmaceutical company, is vying for JB Chemicals and Pharmaceuticals as KKR looks to sel...
- Torrent, Zydus, EQT set to make the cut for $3 bn JB Chemicals buyoutTorrent Pharma and Zydus Lifesciences are vying to acquire JB Chemicals and Pharmaceuticals, with both firms shortlisted by KKR, the curren...
- Torrent Pharma board approves to raise Rs 5,000 croreTorrent Pharmaceuticals, actively seeking to expand through acquisitions, has expressed interest in purchasing Mumbai-based pharmaceutical ...
- Torrent talks for $7 billion Cipla buyout trip on valuationTorrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...
- Torrent Pharma calls the reports of Cipla acquisition as speculative"As a policy we don't want to comment on speculative news," said Sudhir Menon, CFO of Torrent Pharma, referring to reports about the race t...
- Cipla stake sale plan faces hurdle as promoters differ on valuation: ReportCipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...
- Torrent Pharma looks to tie up with CVC Capital to fund Cipla purchaseTorrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least $1.2-1.5 billion for its proposed acquisition of r...
- Why Torrent Pharma is ready to go ahead with the daunting Cipla dealAhmedabad-based Torrent Pharma is seeking financing for a deal with Indian pharmaceutical company Cipla. Torrent Pharma is interested in bu...
- Hot Stocks: Brokerage view on Torrent Pharma, RIL, Voltas and PaytmNomura maintained a buy rating on Torrent Pharma but raised the target to Rs 2199 from Rs 1838 earlier. The potential acquisition of Cipla ...
- Bain dials Dr Reddy's Laboratories to team up for joint Cipla bidPrivate equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the ...
- Torrent Pharma says it has no disclosure to make now on potential Cipla stake buy deal reportsTorrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...
- Realty sector will continue to do well; big rerating in hotel sector over: Daljeet Singh Kohli"Our view right now is that because the real estate sector has played out well, all these stocks have, in terms of valuations, are on a lit...
- Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for fundsRival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...
- Hot Stocks: Brokerage firms on Jindal Stainless, Cipla, Maruti Suzuki and Max HealthcareBernstein maintained an outperform rating on Cipla with a target price of Rs 1262. Cipla is a well-run organization. Blackstone will have t...
- 4+1 stocks that Dipan Mehta would keep in his 5-year-plus basket"Whenever we have seen a change of management like this, it has worked positively for shareholders. Look at what happened in JB Chemicals, ...
- Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PETorrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...
- Sun Pharma tops domestic drugmakers' list; Cipla and Ranbaxy slip two positions eachMumbai-based Sun Pharma has made it to the top of the domestic drug makers’ leaderboard through overseas acquisitions and quadrupling of re...
Load More
